Trademark applications and grants for Alnylam Pharmaceuticals Inc. Alnylam Pharmaceuticals Inc has 78 trademark applications. The latest application filed is for "RNAISCIENCE"
Patent Application | Date |
---|---|
ASSAYS AND METHODS FOR DETERMINING ACTIVITY OF A THERAPEUTIC AGENT IN A SUBJECT 20220307083 - 17/670937 Sah; Dinah ;   et al. | 2022-09-29 |
DELIVERY OF OLIGONUCLEOTIDES TO THE STRIATUM 20220307024 - 17/619633 Nair; Jayaprakash K. ;   et al. | 2022-09-29 |
SERUM AMYLOID P COMPONENT (APCS) iRNA COMPOSITIONS AND METHODS OF USE THEREOF 20220305045 - 17/544984 Fitzgerald; Kevin ;   et al. | 2022-09-29 |
ANGIOPOIETIN-LIKE 3 (ANGPTL3) IRNA COMPOSITIONS AND METHODS OF USE THEREOF 20220290153 - 17/689034 BonDurant; Lucas D. ;   et al. | 2022-09-15 |
COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE 20220290152 - 17/639881 TU; HO-CHOU ;   et al. | 2022-09-15 |
NCAGE Code | 45SR1 | ALNYLAM PHARMACEUTICALS, INC. |
CAGE Code | 45SR1 | ALNYLAM PHARMACEUTICALS, INC. |
CAGE Code | 6WR85 | ALNYLAM PHARMACEUTICALS, INC. |
S.A.M. Registration | 45SR1 [115524410] | ALNYLAM PHARMACEUTICALS, INC. |
DUNS | 115524410 | ALNYLAM PHARMACEUTICALS, INC. |
SEC | 0001178670 | ALNYLAM PHARMACEUTICALS, INC. |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.